This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Enzymology of extracellular NAD metabolism
Cellular and Molecular Life Sciences Open Access 23 March 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$99.00 per year
only $8.25 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout


References
Schmidt, M. S. & Brenner, C. Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter. Nat. Metab. https://doi.org/10.1038/s42255-019-0085-0 (2019).
Grozio, A. et al. Slc12a8 is a nicotinamide mononucleotide transporter. Nat. Metab. 1, 47–57 (2019).
Yoshino, J. & Imai, S. Accurate measurement of nicotinamide adenine dinucleotide (NAD+) with high-performance liquid chromatography. Methods Mol. Biol. 1077, 203–215 (2013).
Yoshino, J., Mills, K. F., Yoon, M. J. & Imai, S. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 14, 528–536 (2011).
Trammell, S. A. & Brenner, C. Targeted, LCMS-based metabolomics for quantitative measurement of NAD+ metabolites. Comput. Struct. Biotechnol. J. 4, e201301012 (2013).
Ramsey, K. M. et al. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 324, 651–654 (2009).
Ratajczak, J. et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nat. Commun. 7, 13103 (2016).
Author information
Authors and Affiliations
Contributions
S.I. and A.G. mainly wrote the correspondence. J.Y. conducted the experiments and analyses discussed in Fig. 1. A.G. performed the experiments and analyses discussed in Fig. 2. K.M., S.B., G.S., K.T., H.C.L., M.M. and Y.S. contributed to the preparation of the correspondence.
Corresponding author
Ethics declarations
Competing interests
A.G. and S.I. are inventors on a patent (PCT/US18/46233) about the Slc12a8 NMN transporter, whose applicant is Washington University; it has been licensed by Teijin Limited. The other authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Grozio, A., Mills, K., Yoshino, J. et al. Reply to: Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter. Nat Metab 1, 662–665 (2019). https://doi.org/10.1038/s42255-019-0086-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-019-0086-z
This article is cited by
-
Enzymology of extracellular NAD metabolism
Cellular and Molecular Life Sciences (2021)